#384 Updates in Chronic Kidney Disease with Dr. Joel Topf
The Curbsiders Internal Medicine Podcast
00:00
Is It a RAS Inhibitor or an Albuminuria?
You'll see a 20% to 30% reduction in that albuminuria and some patients get more dramatic effects. And the funny thing about the, some of the initial trials with these is like the A1C didn't budge much and they still saw the benefit. So that's what, that's how we knew we were on to something with these, with these ones.
Transcript
Play full episode
